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Background: Current evidence-based Adult Treatment Panel (ATP III) guidelines support an LDL-C goal of < 100 mg/dL among individuals defined 
as having coronary heart disease (CHD) or CHD risk equivalents and consideration of an LDL-C goal of < 70 mg/dL for high-risk patients. We 
evaluated the extent of lipid management and the success of achieving LDL-C goals among patients from the ambulatory cardiovascular practices of 
our cardiology trainees who are enrolled in the American College of Cardiology’s Practice Innovation and Clinical Excellence (PINNACLE) Registry.
methods: We queried lipid profile results of patients with CHD or CHD risk equivalents enrolled by our fellows into the PINNACLE Registry between 
2009 and 2012.
results: 2048 patients eligible for lipid-lowering treatment were enrolled between 2009 and 2012. While 98% (n= 2007) of these patients were 
receiving lipid-lowering medication, only 28% (n= 565) had available lipid profile Results. The mean age of these patients was 67.5 ±13.8 years with 
equal numbers of males and females; 61% (n=344) had CHD, 23% (n=125) had diabetes, 11% (n=61) had PAD and 6% (n=32) had CVA. Within this 
group on lipid-lowering medication, 71% (n= 403) had LDL-C levels < 100 mg/dL and 28% (n= 162) had LDL-C levels < 70 mg/dL.
conclusions: This analysis indicates:
1) Over 98% of ambulatory patients in whom lipid-lowering therapy is indicated are receiving therapy. 
2) Significant numbers of individuals who are receiving lipid-lowering therapy are not achieving their recommended LDL-C goals. 
3) Over 70% of patients who receive therapy are not having their lipid profiles assessed or the results are not being communicated to the 
cardiologists. 
Should our findings be confirmed in larger patient populations, the necessity for improvements in data integration between different electronic 
health record systems and improved coordination of care between primary care physicians and cardiologists will be essential.
